Table 4 Distribution of ART-regimens with frequency ≥1% of patients being under treatment (not naïve, no treatment interruption) and under follow up at 20.10.2008, frequency of prescribed substance classes, proportion of class-saving regimens, proportion of viral load below detection limit of regimens and classes (N = 6,655)
Proportion (%) | VL < detection limit (%) | |
|---|---|---|
Regimen | ||
2NRTI+1PI+rtv | 35.5 | 76.1 |
2NRTI+1NNRTI | 35.9 | 88.0 |
3NRTI | 5.2 | 77.7 |
3NRTI+1PI+rtv | 4.7 | 69.7 |
2PI+rtv | 2.6 | 67.9 |
4 NRTI | 1.7 | 60.3 |
3 NRTI + 1 NNRTI | 1.7 | 85.8 |
2NRTI+1NNRTI +1PI +rtv | 1.0 | 79.4 |
2NRTI+2PI+rtv | 1.0 | 65.6 |
1NRTI+ 1PI+rtv | 1.0 | 78.1 |
1 PI + rtv | 1.0 | 64.2 |
other | 8.7 | --- |
Substance classes | ||
NRTI | 90.7 | 79.6 |
NNRTI | 39.5 | 87.4 |
PI | 50.4 | 74.1 |
Fusion-Inhibitors | 1.2 | 62.7 |
Entry-Inhibitors | 0.5 | 50.0 |
Integrase-Inhibitors | 1.7 | 54.5 |
Maturation-Inhibitors | --- | --- |
Class-saving regimen | ||
total | 10.6 | 70.5 |
solely NRTI | 7.4 | 71.3 |
solely PI | 3.2 | 68.6 |